Early Stage Angel Investor Group in Philadelphia

Places You Can Find Us

14th Annual Angel Venture Fair

Event by Shannon Lee

On: 5/1/2012 12:00 PM
Summary: The Angel Venture Fair is the annual consortium of private angel investors across the mid-Atlantic region. In order for the US, and in particular the Mid-Atlantic region of the country to grow economically...

Featured Blog

Why Tech Start-Ups are Staying in Philly

Blog post by Shannon Lee

From the RJMetrics blog - find out why this start-up turned down offers that involved moving their company to New York or Silicon Valley and is instead "doubling-down on Philadelphia". Read the entry...

Investors' Circle Fall Venture Fair is open to ap...

Blog post by Marshall Yang

Investors' Circle, a network of early stage investors, is hosting a venture fair in Philadelphia, Oct 26-28. They will select 10-12 companies to present at the event. To learn more about...

Be Honest about Your Competitors

Blog post by Marshall Yang

In a business plan presentation, being frank about competition wins the respect of investors. Savvy investors know every product/service has substitute. Showing your competitors’ strengths, according...

Angel Investing - Most Frequently Asked Questions

Blog post by Ellen Weber

What's the difference between Angel Investors and Venture Capitalists? What are Angel Groups and how do they work? What makes a company a good candidate for angel investment? We hear...

Obtaining Funding with 5 Magic Slides

Blog post by Sasan Choobineh

Are you an entrepreneur desperately trying to catch an investor's eye? As Socialcast founder Tim Young asserts, the age-old mantra holds true: the simpler, the better. In your company's initial presentation,...

Welcome

Robin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. Robin Hood generally invests $250k to $500k, and collaborates with angels, institutions and VCs in our network. We invest as a single entity in businesses we know and understand, in a way that gets deals done. Since 1999, we have invested over $13M in over 40 companies in industries including software, medical devices, biotech, internet and financial technology.

Apply for Funding

Become an Investor

Recent Investments

DDC Secures Seed Funding from Robin Hood Ventures

Prior to investing in DDC, Robin Hood was a client first. Commenting on Robin Hood’s investment, Dave Kurtz says, “Having used the software ourselves, we knew that DDC had great success ahead of it. We are delighted to be part of that bright future in more ways than one.” Robin Hood currently uses Sonar to track 20 plus investments.

Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate

Novira Therapeutics, Inc., a privately held antiviral drug discovery company developing innovative, first-in-class therapeutics for the treatment of viral diseases, including HBV and HIV, announced that it has completed a second round of seed financing that brings the company’s early financing to approximately $2.5 million, with another $1.0 million obtained in non-dilutive grants. The financing was led by three of Philadelphia’s active angel groups, Delaware Crossing Investor Group, the Mid-Atlantic Angel Group Fund II (MAG II Fund) and Robin Hood Ventures. BioAdvance, the initial investor in the company also participated in the round. Gregory Harriman, M.D., member at Robin Hood Ventures will join Novira’s board of directors as the Board designee for the angel syndicate, and Karen Griffith Gryga, Executive Director of the Mid-Atlantic Angel Group (MAG) Funds (I & II) will take a board observer position.

Recent Exits

March 2011 Fiserv Unveils New Prepaid Solutions

Fiserv has acquired prepaid card processing and other technologies developed by Maverick Network Solutions, a Delaware-based provider of advanced prepaid and reward and incentive card programs. The Delaware start-up and its employees became part of the Fiserv Card Services group on March 1, 2011.

Portfolio Company News

Last updated 6 days ago

Monetate Triple Revenue in 2011

Monetate, the leader in online marketing technology, today announced a record increase in yearly revenue growth, up 278% in 2011 compared to 2010. Coming off a highly successful holiday shopping season, Monetate also reported that its impact on total 2011 holiday ecommerce transactions increased by 300% compared to 2010. At the heart of this surge, Monetate drove roughly 20% of the record-setting $816 million in Black Friday online sales in 2011.

For More: Read Full Text

Record Holiday 2011 Ecommerce Sales Impact by Online Marketing Technology

Philadelphia, PA (January 05, 2012)According to ComScore, online spending reached a record $35.3 billion this holiday season, a 15% increase over last year. At the heart of this surge in online sales lies Philadelphia-basedMonetate, a leading provider of online marketing technology, which announced that its platform drove roughly 20 percent, or $168 million of the record-setting $816 million in Black Friday online sales.

For More: Read Full Text

Surgical implant for dialysis company seeking up to $10 million for series B round

Bioconnect Systems CEO Adam Dakin told MedCity News in a phone interview that the fresh capital would take the company through clinical trials, U.S. regulatory approval and commercialization. The Ambler, Pennsylvania-based company’s Optiflow Vascular Anastomotic System is designed to enhance a surgeon’s ability to create precise vascular connections, aiding the creation of an arteriovenous fistula for vascular access in hemodialysis patients.

For More: Read Full Text| MEDCITY News

Aklero Unveils New MERS Data and Doc Validation Module

Aklero Risk Analytics Inc. has announced the release of DQx for MERS Data and Document Validation Module. The module is part of Q-Close, Aklero's Loan Quality Management Platform, and provides an automated method to validate the accuracy of data resident in the MERS Electronic Registry.

For More: Read Full Text | National Mortgage Professional

QR Pharmaceuticals CEO 2011 Iris Newman award

Dr. Maria Maccecchini, the CEO of QR Pharmaceuticals in Berwyn, Pennsylvania, is poised to accept the 2011 Iris Newman award for her work as a serial entrepreneur in biotechnology, a career that has spanned more than 20 years. The award will be presented by the Alliance of Women Entrepreneurs on Nov. 14.

For More: Serial entrepreneur to receive award | MEDCITY News

Triggers of Lender Scrutiny

NEW OR UNDISCLOSED DEBTS When you’re in the process of buying a home, avoid taking on other debt. “Sometimes borrowers don’t think buying a new car prior to closing a loan is a problem, but it is,” said Carolyn Mitchell, a senior vice president of Aklero Risk Analytics, which provides software for mortgage quality control. Buying a sofa or a furnace on credit could also slow or even scuttle your mortgage closing, depending on your situation, if it pushed your total debt levels beyond acceptable limits.

For More: Read Full Text | New York Times